Poolbeg Pharma (LON:POLB) Issues Earnings Results

Poolbeg Pharma (LON:POLBGet Free Report) announced its quarterly earnings data on Tuesday. The company reported GBX (1.16) (($0.02)) earnings per share (EPS) for the quarter, Digital Look Earnings reports.

Poolbeg Pharma Price Performance

POLB stock opened at GBX 2.50 ($0.03) on Tuesday. The company has a market capitalization of £12.86 million, a PE ratio of 0.00 and a beta of 2.11. Poolbeg Pharma has a 12 month low of GBX 2.25 ($0.03) and a 12 month high of GBX 14.50 ($0.19). The firm’s 50-day moving average is GBX 2.80 and its 200 day moving average is GBX 4.83.

About Poolbeg Pharma

(Get Free Report)

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. Poolbeg comprises a strong and growing portfolio of development assets.

Featured Articles

Receive News & Ratings for Poolbeg Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Poolbeg Pharma and related companies with MarketBeat.com's FREE daily email newsletter.